Locations:
Search
$2M NIH grant will help see if dual-action agent lengthens treatment window
Meet the Director of Cleveland Clinic’s new Center for Immunotherapy and Precision Immuno-Oncology
Defect in myosin binding may explain why a significant percentage of patients do not adequately respond to anti-TNF therapy
Tools to aid in diagnosis, complication management and lifestyle interventions
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Minimizing the translational gap between preclinical testing and clinical outcomes
Phenylacetylglutamine acts via adrenergic receptors and is linked with cardiac events
deepDTnet receives provisional patent to accelerate drug repurposing and minimize the translational gap in development
A mortality risk profile based on lymphocyte count, red blood cell distribution width and C-reactive protein levels
Identifying disease-disease relationships
Noninvasive assessment of carotid artery plaque composition
Advertisement
Advertisement